
HYPR
Hyperfine, Inc.NASDAQHealthcare$1.13+3.67%ClosedMarket Cap: $92.3M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
2.60
P/S
6.81
EV/EBITDA
-1.54
DCF Value
$-1.71
FCF Yield
-31.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.8%
Operating Margin
-273.4%
Net Margin
-262.3%
ROE
-97.4%
ROA
-64.4%
ROIC
-84.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $5.3M | $-5.9M | $-0.06 |
| FY 2025 | $13.6M | $-35.6M | $-0.43 |
| Q3 2025 | $3.4M | $-11.0M | $-0.14 |
| Q2 2025 | $2.7M | $-9.2M | $-0.12 |
Analyst Ratings
View AllLake StreetBuy
2026-03-19Wells FargoEqual Weight
2025-08-15Lake StreetBuy
2025-08-14B. Riley SecuritiesBuy
2025-05-15Wells FargoEqual Weight
2025-05-14Trading Activity
Insider Trades
View AllSainz Mariadirector, officer: President and CEO
SellWed Apr 01
TEISSEYRE THOMASofficer: Chief Operating Officer
SellWed Apr 01
HALE BRETTofficer: CFO and CAO
SellWed Apr 01
TEISSEYRE THOMASofficer: Chief Operating Officer
SellWed Mar 25
HALE BRETTofficer: CFO and CAO
SellWed Mar 25
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.06
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.